These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6470530)

  • 1. Liposome-encapsulated amphotericin B for treatment of disseminated candidiasis in neutropenic mice.
    Lopez-Berestein G; Hopfer RL; Mehta R; Mehta K; Hersh EM; Juliano RL
    J Infect Dis; 1984 Aug; 150(2):278-83. PubMed ID: 6470530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylaxis of murine candidiasis via application of liposome-encapsulated amphotericin B and a muramyl dipeptide analog, alone and in combination.
    Mehta RT; Lopez-Berestein G; Hopfer RL; Mehta K; White RA; Juliano RL
    Antimicrob Agents Chemother; 1985 Oct; 28(4):511-3. PubMed ID: 4073873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylaxis of Candida albicans infection in neutropenic mice with liposome-encapsulated amphotericin B.
    Lopez-Berestein G; Hopfer RL; Mehta R; Mehta K; Hersh EM; Juliano RL
    Antimicrob Agents Chemother; 1984 Mar; 25(3):366-7. PubMed ID: 6721469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of liposomal-amphotericin B against C. albicans infection in mice.
    Lopez-Berestein G; McQueen T; Mehta K
    Cancer Drug Deliv; 1985; 2(3):183-9. PubMed ID: 4052931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of antibody-bearing liposomal amphotericin B in the treatment of systemic candidiasis in a neutropenic murine model.
    Belay T; Hospenthal DR; Rogers AL; Patterson MJ
    J Med Vet Mycol; 1991; 29(6):419-21. PubMed ID: 1815035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment and prophylaxis of disseminated infection due to Candida albicans in mice with liposome-encapsulated amphotericin B.
    Lopez-Berestein G; Mehta R; Hopfer RL; Mills K; Kasi L; Mehta K; Fainstein V; Luna M; Hersh EM; Juliano R
    J Infect Dis; 1983 May; 147(5):939-45. PubMed ID: 6842027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative efficacies of cilofungin (Ly121019) and amphotericin B against disseminated Candida albicans infection in normal and granulocytopenic mice.
    Khardori N; Nguyen H; Stephens LC; Kalvakuntla L; Rosenbaum B; Bodey GP
    Antimicrob Agents Chemother; 1993 Apr; 37(4):729-36. PubMed ID: 8494367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of systemic candidiasis in a neutropenic murine model using immunoglobulin G bearing liposomal amphotericin B.
    Belay T; Hospenthal DR; Rogers AL; Patterson MJ
    Mycopathologia; 1993 Jul; 123(1):9-17. PubMed ID: 8247096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic evaluation of free and liposome-encapsulated amphotericin B in the treatment of systemic candidiasis in mice.
    Gondal JA; Swartz RP; Rahman A
    Antimicrob Agents Chemother; 1989 Sep; 33(9):1544-8. PubMed ID: 2684010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the efficacies of amphotericin B, fluconazole, and itraconazole against a systemic Candida albicans infection in normal and neutropenic mice.
    Van t Wout JW; Mattie H; van Furth R
    Antimicrob Agents Chemother; 1989 Feb; 33(2):147-51. PubMed ID: 2541654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of experimental murine candidiasis with liposome-encapsulated amphotericin B].
    Sasahara T
    Kansenshogaku Zasshi; 1989 Dec; 63(12):1301-7. PubMed ID: 2621383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of hepatosplenic candidiasis with a liposomal amphotericin B preparation.
    Björkholm M; Kållberg N; Grimfors G; Eklund LH; Eksborg S; Juneskans OT; Udén AM
    J Intern Med; 1991 Aug; 230(2):173-7. PubMed ID: 1865169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and characterization of oral lipid-based amphotericin B formulations with enhanced drug solubility, stability and antifungal activity in rats infected with Aspergillus fumigatus or Candida albicans.
    Wasan EK; Bartlett K; Gershkovich P; Sivak O; Banno B; Wong Z; Gagnon J; Gates B; Leon CG; Wasan KM
    Int J Pharm; 2009 May; 372(1-2):76-84. PubMed ID: 19236839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation of amphotericin-B nephrotoxicity in the candidiasis rat model.
    Luke DR; Wasan KM; Verani RR; Brunner LJ; Berens KL; Vadiei K; Lopez-Berestein G
    Nephron; 1991; 59(1):139-44. PubMed ID: 1944727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of escalating doses of liposomal amphotericin B (AmBisome) against hematogenous Candida lusitaniae and Candida krusei infection in neutropenic mice.
    Karyotakis NC; Anaissie EJ
    Antimicrob Agents Chemother; 1994 Nov; 38(11):2660-2. PubMed ID: 7872764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the efficacy of polyenes and triazoles against hematogenous Candida krusei infection in neutropenic mice.
    Karyotakis NC; Anaissie EJ; Hachem R; Dignani MC; Samonis G
    J Infect Dis; 1993 Nov; 168(5):1311-3. PubMed ID: 8228370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: a preliminary study.
    Lopez-Berestein G; Fainstein V; Hopfer R; Mehta K; Sullivan MP; Keating M; Rosenblum MG; Mehta R; Luna M; Hersh EM
    J Infect Dis; 1985 Apr; 151(4):704-10. PubMed ID: 3973417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fungal infection and fever of unknown origin in neutropenic patients.
    Bodey GP
    Am J Med; 1986 May; 80(5C):112-9. PubMed ID: 3717185
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of invasive Aspergillus sinusitis with liposomal-amphotericin B.
    Weber RS; Lopez-Berestein G
    Laryngoscope; 1987 Aug; 97(8 Pt 1):937-41. PubMed ID: 3613794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of aminocandin (IP960) compared with amphotericin B and fluconazole in a neutropenic murine model of disseminated infection caused by a fluconazole-resistant strain of Candida tropicalis.
    Warn PA; Sharp A; Morrissey G; Denning DW
    J Antimicrob Chemother; 2005 Sep; 56(3):590-3. PubMed ID: 16046462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.